Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-29 @ 4:27 PM
Study NCT ID:
NCT01129206
Status:
COMPLETED
Last Update Posted:
2016-06-01
First Post:
2010-05-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-05-21
First Submit QC Date:
None
Study First Post Date:
2010-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-15
Results First Submit QC Date:
None
Results First Post Date:
2015-10-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-25
Last Update Post Date:
2016-06-01
Last Update Post Date Type:
ESTIMATED